General Information of the Compound
Compound ID |
CP0709373
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine hydrochloride
Show/Hide
|
||||||||||||||||||
Synonyms |
-Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline
26SU0NEF5F
4-(2&
445430-58-0
BDBM25919
BMS-345541
BMS-345541 (free base)
BMS-345541 free base
BMS-345541(free base)
BMS345541
C14H17N5
CHEBI:91340
CHEMBL249697
CTK8E9618
DTXSID60196216
GTPL5669
HMS2043P05
HMS3653F06
IKK Inhibitor III
IKK Inhibitor III, BMS-345541
KS-00001CRN
Kinome_3215
MolPort-035-395-836
N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine
PSPFQEBFYXJZEV-UHFFFAOYSA-N
SCHEMBL118886
UNII-26SU0NEF5F
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H18ClN5
|
||||||||||||||||||
Molecular Weight |
291.786
|
||||||||||||||||||
Canonical SMILES |
Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1.Cl
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H17N5.ClH/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15;/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18);1H
Show/Hide
|
||||||||||||||||||
InChIKey |
MIDKPVLYXNLFGZ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound